Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

Visual inspection of cervix with Lugol's iodine for early detection of premalignant & malignant lesions of cervix.

Ghosh P, Gandhi G, Kochhar PK, Zutshi V, Batra S.

Indian J Med Res. 2012 Aug;136(2):265-71.

2.

Evaluation of visual inspection with acetic acid and Lugol's iodine as cervical cancer screening tools in a low-resource setting.

Qureshi S, Das V, Zahra F.

Trop Doct. 2010 Jan;40(1):9-12. doi: 10.1258/td.2009.090085. Epub 2009 Dec 11.

PMID:
20008057
3.

Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.

Sarian LO, Derchain SF, Naud P, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Serpa-Hammes L, Matos J, Gontijo R, Bragança JF, Lima TP, Maeda MY, Lörincz A, Dores GB, Costa S, Syrjänen S, Syrjänen K.

J Med Screen. 2005;12(3):142-9.

PMID:
16156945
4.

Comparative study of effectiveness of Pap smear versus visual inspection with acetic acid and visual inspection with Lugol's iodine for mass screening of premalignant and malignant lesion of cervix.

Consul S, Agrawal A, Sharma H, Bansal A, Gutch M, Jain N.

Indian J Med Paediatr Oncol. 2012 Jul;33(3):161-5. doi: 10.4103/0971-5851.103143.

5.

Screening of cervical neoplasia in HIV-infected women in India.

Joshi S, Sankaranarayanan R, Muwonge R, Kulkarni V, Somanathan T, Divate U.

AIDS. 2013 Feb 20;27(4):607-15. doi: 10.1097/QAD.0b013e32835b1041.

PMID:
23079814
6.

Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study.

Syrjänen K, Naud P, Derchain S, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Hammes LS, Matos J, Gontijo R, Sarian L, Braganca J, Arlindo FC, Maeda MY, Lörincz A, Dores GB, Costa S, Syrjänen S.

Anticancer Res. 2005 Sep-Oct;25(5):3469-80.

7.

Diagnostic value of acetic acid comparing with conventional Pap smear in the detection of colposcopic biopsy-proved CIN.

Hegde D, Shetty H, Shetty PK, Rai S.

J Cancer Res Ther. 2011 Oct-Dec;7(4):454-8. doi: 10.4103/0973-1482.92019.

8.

Cervical digital photography for screening of uterine cervix cancer and its precursor lesions in developing countries.

Hillmann Ede C, Dos Reis R, Monego H, Appel M, Hammes LS, Rivoire WA, Capp E.

Arch Gynecol Obstet. 2013 Jul;288(1):183-9. doi: 10.1007/s00404-013-2745-8. Epub 2013 Feb 12.

PMID:
23400355
9.

Performance characteristics of Pap test, VIA, VILI, HR-HPV testing, cervicography, and colposcopy in diagnosis of significant cervical pathology.

Longatto-Filho A, Naud P, Derchain SF, Roteli-Martins C, Tatti S, Hammes LS, Sarian LO, Eržen M, Branca M, de Matos JC, Gontijo R, Maeda MY, Lima T, Costa S, Syrjänen S, Syrjänen K.

Virchows Arch. 2012 Jun;460(6):577-85. doi: 10.1007/s00428-012-1242-y. Epub 2012 May 5.

PMID:
22562132
10.
11.

Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, India.

Sankaranarayanan R, Wesley R, Thara S, Dhakad N, Chandralekha B, Sebastian P, Chithrathara K, Parkin DM, Nair MK.

Int J Cancer. 2003 Sep 1;106(3):404-8.

12.

Concurrent evaluation of visual, cytological and HPV testing as screening methods for the early detection of cervical neoplasia in Mumbai, India.

Shastri SS, Dinshaw K, Amin G, Goswami S, Patil S, Chinoy R, Kane S, Kelkar R, Muwonge R, Mahé C, Ajit D, Sankaranarayanan R.

Bull World Health Organ. 2005 Mar;83(3):186-94. Epub 2005 Mar 16.

13.

A comparative study of cervical cancer screening methods in a rural community setting of North India.

Satyanarayana L, Asthana S, Bhambani S, Sodhani P, Gupta S.

Indian J Cancer. 2014 Apr-Jun;51(2):124-8. doi: 10.4103/0019-509X.138172.

14.

Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India.

Arbyn M, Sankaranarayanan R, Muwonge R, Keita N, Dolo A, Mbalawa CG, Nouhou H, Sakande B, Wesley R, Somanathan T, Sharma A, Shastri S, Basu P.

Int J Cancer. 2008 Jul 1;123(1):153-60. doi: 10.1002/ijc.23489.

15.
16.

Conventional Pap smear and liquid-based cytology as screening tools in low-resource settings in Latin America: experience of the Latin American screening study.

Longatto-Filho A, Maeda MY, Erzen M, Branca M, Roteli-Martins C, Naud P, Derchain SF, Hammes L, Matos J, Gontijo R, Sarian LO, Lima TP, Tatti S, Syrjänen S, Syrjänen K.

Acta Cytol. 2005 Sep-Oct;49(5):500-6.

PMID:
16334026
17.

Efficacy of visual inspection of the cervix using acetic acid in cervical cancer screening: a comparison with cervical cytology.

Akinola OI, Fabamwo AO, Oshodi YA, Banjo AA, Odusanya O, Gbadegesin A, Tayo A.

J Obstet Gynaecol. 2007 Oct;27(7):703-5.

PMID:
17999297
18.

Direct visual inspection of the cervix with Lugol iodine for the detection of premalignant lesions.

El-Shalakany AH, Saeed MM, Abdel-Aal MR, El-Nakeeb AH, Noseirat N, Ayyad SB, El Din ZS.

J Low Genit Tract Dis. 2008 Jul;12(3):193-8. doi: 10.1097/LGT.0b013e31815f527c.

PMID:
18596460
19.

[Evaluation of five screening methods for an early detection of cervical cancer and its precancerous lesions in Zhejiang province].

Fei HL, Cheng YF, Cheng XD, Chen XD, Ye F, Lü WG, Xie X.

Zhonghua Yi Xue Za Zhi. 2011 Feb 1;91(5):309-12. Chinese.

PMID:
21419004
20.

[Evaluation on the visual inspection with Lugol's iodine in cervical cancer screening program].

Li N, Ma CP, Sun LX, Zhang YZ, Shao SL, Xing JX, Bao YP, Huang RD, He LJ, Qiao YL.

Zhonghua Liu Xing Bing Xue Za Zhi. 2006 Jan;27(1):15-8. Chinese.

PMID:
16737565

Supplemental Content

Support Center